PuraPharm (HKG:1498) revised the timetable for its proposed capital reduction and subdivision of unissued shares to Feb. 24, according to a Monday filing with the Hong Kong bourse.
The court hearing for confirmation is scheduled for Jan. 27, in the Cayman Islands. Subject to approval, the changes will take effect on Feb. 24, with trading in the new ordinary shares commencing the same day.
Shareholders can exchange old certificates for new ones from Feb. 24 to March 24.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。